CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer
Open Access
- 20 July 2026
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 219, 109535
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca Canada
- BC Cancer Foundation
- AstraZeneca
This publication has 18 references indexed in Scilit:
- Immune checkpoint inhibition alters patterns of failure in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapyJournal of Cancer Research and Clinical Oncology, 2025
- Prediction of brain metastasis development with DNA methylation signaturesNature Medicine, 2024
- First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysisStrahlentherapie und Onkologie, 2023
- Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint InhibitorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancerJournal of Radiation Research, 2022
- Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2022
- Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumabRadiotherapy and Oncology, 2020
- Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyJournal of Clinical Oncology, 2019
- Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung CancerJAMA Oncology, 2017
- Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyThe Lancet Oncology, 2016